Insider Transactions in Q4 2021 at Arcus Biosciences, Inc. (RCUS)
Insider Transaction List (Q4 2021)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Dec 20
2021
|
Jennifer Jarrett Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
34,822
-10.05%
|
$1,427,702
$41.6 P/Share
|
Dec 17
2021
|
Terry J Rosen Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
2,943
-0.34%
|
$117,720
$40.11 P/Share
|
Dec 17
2021
|
Jennifer Jarrett Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
7,118
-1.37%
|
$284,720
$40.11 P/Share
|
Dec 17
2021
|
Juan C. Jaen President |
SELL
Open market or private sale
|
Direct |
1,108
-0.14%
|
$44,320
$40.11 P/Share
|
Dec 17
2021
|
Ii Robert C. Goeltz Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
621
-2.09%
|
$24,840
$40.11 P/Share
|
Dec 17
2021
|
Carolyn C. Tang General Counsel |
SELL
Open market or private sale
|
Direct |
622
-0.87%
|
$24,880
$40.11 P/Share
|
Dec 16
2021
|
Terry J Rosen Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
2,299
-0.53%
|
$91,960
$40.03 P/Share
|
Dec 16
2021
|
Jennifer Jarrett Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
5,560
-2.03%
|
$222,400
$40.03 P/Share
|
Dec 16
2021
|
Juan C. Jaen President |
SELL
Open market or private sale
|
Direct |
865
-0.21%
|
$34,600
$40.03 P/Share
|
Dec 16
2021
|
Ii Robert C. Goeltz Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
485
-3.02%
|
$19,400
$40.03 P/Share
|
Dec 16
2021
|
Carolyn C. Tang General Counsel |
SELL
Open market or private sale
|
Direct |
487
-1.31%
|
$19,480
$40.03 P/Share
|